$124 Million is the total value of CITIZENS & NORTHERN CORP's 91 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BMY | New | Bristol Myers Squibb Co | $1,330,000 | – | 24,458 | +100.0% | 1.07% | – |
DGX | New | Quest Diagnostics Inc | $209,000 | – | 2,124 | +100.0% | 0.17% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
iShares S&P MidCap 400 Index Fd | 42 | Q3 2023 | 17.2% |
Citizens & Northern Corp | 42 | Q3 2023 | 5.2% |
Microsoft Corp | 42 | Q3 2023 | 4.3% |
Exxon Mobil Corp | 42 | Q3 2023 | 2.5% |
Procter & Gamble Co | 42 | Q3 2023 | 2.9% |
Nike, Inc. Class B | 42 | Q3 2023 | 2.8% |
Abbott Labs | 42 | Q3 2023 | 1.9% |
Oracle Corp | 42 | Q3 2023 | 2.1% |
McDonalds Corp | 42 | Q3 2023 | 1.6% |
Johnson & Johnson | 42 | Q3 2023 | 2.2% |
View CITIZENS & NORTHERN CORP's complete holdings history.
Latest filings
Type | Filed |
---|---|
4 | 2024-06-10 |
4 | 2024-06-10 |
4 | 2024-05-30 |
4 | 2024-05-30 |
4 | 2024-05-30 |
4 | 2024-05-30 |
4 | 2024-05-30 |
4 | 2024-05-30 |
4 | 2024-05-30 |
4 | 2024-05-30 |
View CITIZENS & NORTHERN CORP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.